AVROBIO AVRO 深 沪
已收盘 06-20 16:00:00 美东时间
1.40
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.40
- 总市值 6280.47万
- 52周最高 19.80
- 市盈率 静 0.43
- 换手率 0.00%
- 52周最低 10.5612
- 委 比 0.00%
- 总股本 4486.05万
- 历史最高 644.40
- 量 比 0
- 振 幅 0.00%
- 历史最低 6.72
- 每 手 1
- 风险率 1.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tectonic draws bullish view at Wells Fargo on lead asset
Tectonic Therapeutic (NASDAQ:TECX) traded higher on Thursday after Wells Fargo launched its coverage with an Overweight recommendation and a $55 per share target, mainly highlighting its lead candidat...
08-23 01:56
Tectonic gets FDA okay to begin clinical testing for lead drug TX45
Tectonic Therapeutics (NASDAQ:TECX) said it has received FDA clearance for its Investigational New Drug application for TX45 for the treatment of a type of pulmonary hypertension. The company said it ...
07-31 06:54
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
CAMBRIDGE, Mass., June 24, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disea...
06-24 20:58
Avrobio Merges with Tectonic, Emerges as Tectonic Therapeutic
The latest announcement is out from Avrobio (AVRO). AVROBIO has finalized its m...
06-21 05:04
Tectonic, AVROBIO complete merger, announce $130.7M private placement
Tectonic Therapeutic (TECX) announced the closing of its planned merger with AVROBIO (NASDAQ:AVRO), along with a concurrent $130.7 private placement. The combined company will operate under the name...
06-21 04:54
快讯 | AVROBIO - 6月11日，公司股东批准按1:3至1:30的区间比率效力于Avro已发行普通股的逆向股份拆细
AVROBIO - on June 11, Co's Stockholders Approved Effecting Reverse Stock Split ...
06-15 04:34
Tectonic Therapeutic appoints Daniel Lochner as CFO
Tectonic Therapeutic (NASDAQ:AVRO) on Monday announced the appointment of Daniel Lochner as Chief Financial Officer. Prior to joining Tectonic, Lochner served as Chief Business Officer and CFO of Viat...
06-04 04:24
AVROBIO’s Pivot and Tectonic Merger: Navigating the New Complex Regulatory Terrain
Avrobio (AVRO) has disclosed a new risk, in the Share Price & Shareholder R...
05-11 14:01
盘前双双大涨！Alvotech(ALVO.US)梯瓦制药(TEVA.US)仿制药Simlandi获批
© Reuters. 盘前双双大涨！Alvotech(ALVO.US)梯瓦制药(TEVA.US)仿制药Simlandi获批 ...
02-26 19:10
Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm
NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek ...
02-02 03:25
